MOEID RIAZ: Open Payments
NPI 1992347876 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,577 in 131 payments from 38 companies in 2025. Trend: 2023 $1,782 · 2024 $1,712 · 2025 $2,577
Food & beverage: $2,577
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $313 |
| AstraZeneca Pharmaceuticals LP | 12 | $261 |
| Merck Sharp & Dohme LLC | 13 | $238 |
| PFIZER INC. | 14 | $206 |
| Daiichi Sankyo Inc. | 6 | $127 |
| Janssen Biotech, Inc. | 5 | $120 |
| GlaxoSmithKline, LLC. | 6 | $115 |
| TerSera Therapeutics LLC | 5 | $108 |
| Eisai Inc. | 5 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
Products named: KEYTRUDA, Enhertu, ELAHERE, IMBRUVICA, Lenvima, EPKINLY, JEMPERLI, XTANDI.
Industry payments across MO — which companies pay providers there.
